Nacimbio, a division of the Rostec State Corporation, has committed to delivering an impressive 69 million doses of influenza vaccines to various regions across the Russian Federation by November 2023. Deliveries are carried out under the state order of the Ministry of Health of the Russian Federation and will be implemented in two stages.
By September 1, a total of 30.7 million doses of medications will be delivered to the country’s medical institutions. This includes 20.7 million doses of the highly effective trivalent vaccine Sovigripp, as well as 10 million doses of the advanced quadrivalent vaccine Ultrix Quadri. Then, by December, another 38.3 million doses will be transferred to the constituent entities of the Russian Federation. The preparations will be used for immunization of the population within the framework of the National Immunization Schedule.
